Navigation Links
Cordis Announces Discontinuation of NEVO™ Sirolimus-Eluting Coronary Stent
Date:6/15/2011

will focus on access, diagnostic and therapeutic products for cardiology procedures, products to diagnose, access and treat lower extremity disease, and the INCRAFT™ Stent-Graft System, the company's new investigational device for treating abdominal aortic aneurysm (AAA). The company also recently received FDA approval for the EXOSEAL™ Vascular Closure Device.  

These businesses generated 2010 sales of $1.9 billion*, representing an operational growth rate of 8 percent versus the prior year.  Together, these businesses share the common goal of providing lasting and minimally invasive treatments to improve and extend the lives of patients suffering from cardiovascular disease. These businesses will also evaluate opportunities in areas where significant need and promising technologies exist.

The company intends to close two manufacturing facilities:  Cashel, Ireland, where the NEVO™ Stent was to be produced, and San German, Puerto Rico, the manufacturing site for the CYPHER® Stent products.  The company will also consolidate its Research and Development project teams in Fremont, California.  Overall, the company expects to reduce 900 - 1,000 positions, subject to any consultation procedures on these plans in countries where required.

In a separate news release today, Cordis' parent company, Johnson & Johnson, announced the financial implications of Cordis' restructuring plans.

Dynamics in the DES market have changed considerably in recent years and continue to evolve in areas such as demand, pricing and reimbursement, and regulatory requirements for breakthrough new technologies. Unlicensed competition from products that infringe Cordis patents, both owned and licensed, has eroded CYPHER® Stent pricing, sales and market share, and has dampened the prospects for NEVO™ Stent commercialization. At the same time, long-term data show some competitive DES offerings will adequately
'/>"/>

SOURCE Cordis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cordis Unveils Next Generation CoCr Coronary Stent
2. CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
3. Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... YORK , January 15, 2014 ... Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding ... on January 7, 2014, the Company,s board of directors ... Weiner as its new member of the board. ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... Forecast – Worldwide Analysis ... Market Analysis Insulin ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... that a new market research report is available in ... http://www.reportlinker.com/p0488682/Cancer-Reports-Bundle.html The Cancer ... a 15% discount off the individual reports being purchased separately: ... Therapies. - Cancer Cell Therapy Markets. ...
... president John F. Kennedy designated the month of May as ... a long-standing tradition to pay tribute to older adults. At ... birthday, according to the Administration on Aging. In 2009, this ... shift and older adults rely on the support of their ...
Cached Medicine Technology:Reportlinker Adds Cancer Reports Bundle 2Reportlinker Adds Cancer Reports Bundle 3Reportlinker Adds Cancer Reports Bundle 4Reportlinker Adds Cancer Reports Bundle 5Reportlinker Adds Cancer Reports Bundle 6Reportlinker Adds Cancer Reports Bundle 7Reportlinker Adds Cancer Reports Bundle 8May is Older Americans Month 2
(Date:7/11/2014)... 2014 On Tuesday, July 9, Eric ... VA office joined CBS affiliate WUSA’s Andrea Roane ... the audience about the number of ways Shady Grove ... motherhood possible for women after they undergo cancer ... patients in the developing field known as oncofertility which ...
(Date:7/11/2014)... Beach, CA (PRWEB) July 11, 2014 ... pure Artichoke Leaf Extract dietary supplements to aid in ... an action necessary to facilitate metabolism of fat. Formulated ... Superior Labs Artichoke Leaf Extract is available in all-natural, ... pure artichoke extract. , Health Benefits of Artichoke ...
(Date:7/11/2014)... July 11, 2014 This morning(July 9th, 2014 ... Morning Memphis to discuss the illegal immigration crisis at our ... of McAllen, Texas. , Dr. Flinn told Good Morning Memphis ... absolutely wide open… The problem is that they do not ... of people per day are coming into the border; the ...
(Date:7/11/2014)... Yisrayl Hawkins, Pastor and Overseer of The House of ... the children from other nations, who are trying to escape ... President Barack Obama is fighting to let these children get ... wants to help him. , “It is really heartbreaking ... Salvador being treated as if they are doing something wrong ...
(Date:7/11/2014)... Minneapolis, MN (PRWEB) July 11, 2014 ... now offering complimentary perineplasty for each qualifying patient ... Steven Shu has been performing laser vaginal rejuvenation, ... over three years. The LVR procedure decreases the ... effectively enhances vaginal muscle tone, strength, and control, ...
Breaking Medicine News(10 mins):Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 2Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 3Health News:Baby After Cancer Is a Reality as Shady Grove Fertility Provides Successful Treatment for Cancer Survivors 4Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 2Health News:Artichoke Leaf Extract Released by SuperiorLabs Now Available on Amazon.com With 2 Day Prime Shipping 3Health News:Senate Candidate, George Flinn on Fox13 NEWS About the Border Crisis 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 2Health News:Yisrayl Hawkins Backs Barack Obama’s Pleas to Let the Children Come to the U.S. in New Letter 3Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 2Health News:Shu Cosmetic Surgery of Twin Cities Now Offers Complimentary Perineoplasty in Laser Vaginal Rejuvenation 3
... major limitation of endoscopic ultrasound (EUS) examination is ... of a lesion. The differential diagnosis between benign ... based on the EUS appearance is difficult and ... confirmation of malignancy. Elastography has recently been presented ...
... of hepatitis C (HCV) infection with type II mixed ... A research article to be published on April 7, ... addresses this question. The research team led by Professor ... People,s Liberation Army 161 Hospital in Wuhan used IgH ...
... Calgary, AB- The most disabling aspect of Tourette syndrome ... conjunction with another disorder. The most frequent co-occurring ... disorder (ADHD), though the cause of this association is ... but having two means coping with more than twice ...
... , , WEDNESDAY, April 15 (HealthDay News) -- If you have ... or pop in a CD of mellow songs. , Hospital ... rate and blood pressure just by listening to music, a ... report, published in the latest issue of The Cochrane ...
... Their children are prone to risky behaviors, study finds , , ... away at war, their teenage children are more likely to ... grades at school, a new study has found. , But ... during the deployment tended to fare better. , "Adolescents are ...
... Inc. ("Rib-X" or the "Company"), a development-stage company focused ... the treatment of antibiotic-resistant infections, today announced the issuance ... State Intellectual Property Office of the People,s Republic of ... 0021883.9 to Rib-X. This patent provides composition of ...
Cached Medicine News:Health News:Can EUS elastography help distinguish benign from malignant tissue? 2Health News:Do patients at risk for B-cell malignancy need antiviral treatment? 2Health News:Tourette syndrome misconceptions only one battle for patients 2Health News:Soothing Songs Please the Heart 2Health News:Deployment Takes Toll on Military Moms and Teens 2Health News:Deployment Takes Toll on Military Moms and Teens 3Health News:Rib-X Granted Key Antibiotic Patent in China 2
Dome shape, extra smooth tip provides safe insertion through wound & manipulation within the eye. 45, 4.0mm from end...
...
...
...
Medicine Products: